Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer

Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer

BackgroundBladder cancer (BLCA) is a common urinary system malignancy with a significant morbidity and death rate worldwide. Non-muscle invasive BLCA accounts for over 75% of all BLCA cases. The imbalance of tumor metabolic pathways is associated with tumor formation and proliferation. Pyrimidine me...

Full description

Bibliographic Details
Main Authors: Zixuan Wu, Xiaohuan Li, Zhenchang Gu, Xinhua Xia, Jing Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
BLCA
PyMGs
immunity
m 6 A and immune checkpoint
drug prediction
CNV
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1102518/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1102518/full

Similar Items